NEW YORK — Patients with rheumatoid arthritis (RA) carry a high risk for cardiovascular events, but mounting clinical evidence suggests they're being undertreated to manage that risk. Rheumatologists ...

First published in 2010, the EULAR recommendations for the management of RA, the most frequent inflammatory rheumatic disease ...

Cedars-Sinai’s center provides personalized, multidisciplinary care for RA and related conditions, improving patient outcomes and quality of life. Dr. Jon Giles' research explores autoimmune disease ...

Treating rheumatoid arthritis (RA) typically means taking drugs to address the inflammatory process that leads to joint pain in RA. These drugs may be taken by mouth, or by injection or infusion. But ...

In a real-world, prospective study, upadacitinib demonstrated great potential for the treatment of rheumatoid arthritis (RA) regardless of a patient’s baseline C-reactive protein (CRP) levels.

Please provide your email address to receive an email when new articles are posted on . “It has long been recognized that patients with RA suffer more frequent heart attacks and strokes,” Daniel ...

Early detection and treatment of rheumatoid arthritis (RA; within 12 weeks of symptom onset) results in lower treatment-related costs over 5 years compared with later diagnosis. The study enrolled 431 ...

Since their first publication in 2010, the EULAR recommendations for the use of disease-modifying anti-rheumatic treatments (DMARDs) in people with RA have become a most important publication in the ...

Functional MRI studies have established that subjective feelings of pain and fatigue have objective correlates in terms of neuronal activity patterns. This study sought to determine whether neural ...

A widely used treatment for rheumatoid arthritis may offer an unexpected cardiovascular benefit. Methotrexate has been a staple treatment for rheumatoid arthritis for decades, valued for its ability ...